Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Myasthenia Gravis × blinatumomab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Burkitt Lymphoma 3 Neoplasm, Residual 2 Leukemia 2 Myasthenia Gravis 1 Leukemia, Lymphoid 1 Graft vs Host Disease 1

Interventions

telitacicept 3 rozanolixizumab 2 Prednisone 2 ravulizumab 1 fludarabine 1 blinatumomab 1 Pyridostigmine Bromide 1 Psychodrama 1 Prednisolone 1 Population Groups 1 Cyclophosphamide 1 Art Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06836973 2025-03-25

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Da, Yuwei, M.D.

Phase 2/3 Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡